Empiric Management of Catheter‑Associated Urinary Tract Infection in ICU Patients

Diagnostic Approach

Obtain a urine specimen for culture before initiating any antimicrobial therapy in ICU patients with suspected catheter‑associated UTI. This ensures appropriate pathogen identification given the broad spectrum of possible organisms and high resistance rates. 1
If the indwelling catheter has been in place for ≥ 2 weeks, replace it and obtain the culture from the new catheter rather than the existing one, because biofilm on the old catheter may not reflect the true bladder infection. 1

Replace the indwelling catheter at the onset of catheter‑associated UTI when it has been in place ≥ 2 weeks and continued catheter use is still required. Catheter replacement accelerates symptom resolution and lowers the risk of subsequent bacteriuria and recurrent infection. [1][2]

Base initial empiric therapy on local antimicrobial‑resistance data whenever such surveillance information is available, to improve the likelihood of covering the causative pathogen. 2
Fluoro‑quinolones are recommended by guideline evidence for empiric treatment, provided that local resistance patterns do not contraindicate their use. [1][2]
Moxifloxacin should be avoided because urinary concentrations sufficient for treating UTI are uncertain. 2
Adjust the antimicrobial regimen promptly once culture and susceptibility results are obtained. This de‑escalation strategy aligns with stewardship principles. 2

Administer a 7‑day course of antibiotics for patients who achieve prompt clinical response (defervescence within 72 hours). This duration is sufficient for symptom resolution in responders. [1][2]
Provide a 10–14‑day course for patients with delayed clinical response (defervescence after > 72 hours). The extended duration ensures eradication in slower responders. [1][2]
The recommended duration applies regardless of whether the catheter remains in place during therapy. [1][2]
A 5‑day levofloxacin regimen (750 mg IV or PO once daily) may be considered in non‑severely ill patients. In catheterized patients, this short course achieved higher microbiologic eradication (≈ 79 %) compared with a 10‑day ciprofloxacin regimen (≈ 53 %). 1
Shortened courses with other fluoroquinolones lack sufficient evidence and are not recommended. 1
A 3‑day antimicrobial regimen can be considered for women ≤ 65 years who develop catheter‑associated UTI after catheter removal and have no upper‑tract symptoms. [1][2]

Do not screen for or treat asymptomatic bacteriuria in catheterized patients, except in pregnant women or those undergoing endoscopic urologic procedures that breach the mucosa. Treating asymptomatic bacteriuria leads to unnecessary antimicrobial exposure. 3
If defervescence is not achieved within 72 hours, extend the antibiotic course and obtain urologic evaluation to rule out unresolved infection or anatomic issues. 2